Arlington, MA, United States of America

Kristin Thompson

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 99(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kristin Thompson: Pioneering Nucleic Acid Research in Arlington, MA

Introduction: Kristin Thompson is a prominent inventor based in Arlington, Massachusetts, recognized for her significant contributions to the field of nucleic acid therapeutics. With a notable portfolio of four patents, she has emerged as a leading figure in innovative research and development.

Latest Patents: Among her notable patents are "Materials and methods for the generation of fully 2'-modified nucleic acid transcripts" and "Materials and methods for the generation of transcripts comprising modified nucleotides." These patents provide innovative materials and methods for producing aptamer therapeutics with fully modified nucleotide triphosphates, showcasing Kristin's expertise in enhancing the efficacy and specificity of nucleic acid-based treatments.

Career Highlights: Kristin's career has been marked by her role at Archemix Corporation, where she has made significant strides in her research. Her work has contributed to advancing the understanding and application of nucleic acids in therapeutic settings, playing a crucial role in the development of new technologies that can potentially revolutionize treatments for various diseases.

Collaborations: Throughout her career, Kristin has collaborated with esteemed colleagues, including John Louis Diener and Anthony Dominic Keefe. These collaborations have fostered an environment of innovation, driving forward the collective research efforts within the organization and beyond.

Conclusion: Kristin Thompson exemplifies the spirit of innovation in the realm of nucleic acid research. Her patents not only reflect her dedication to advancing therapeutic techniques but also demonstrate her capacity to work collaboratively with other experts in the field. As she continues her research at Archemix Corporation, the impact of her contributions will undoubtedly resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…